Reducing CIED lead dislodgements: Faithful alignment to small things

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/147189/1/pace13545.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/147189/2/pace13545_am.pd

CRT-D Therapy in Patients with Left Ventricular Dysfunction and Atrial Fibrillation

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72803/1/j.1542-474X.2005.00072.x.pd

Adverse Interaction Between a Left Ventricular Assist Device and an Implantable Cardioverter Defibrillator

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/73346/1/j.1540-8167.2007.00805.x.pd

Temporal Stability of the Location of the Esophagus in Patients Undergoing a Repeat Left Atrial Ablation Procedure for Atrial Fibrillation or Flutter

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/71884/1/j.1540-8167.2007.01051.x.pd

Comparison of outcomes in patients undergoing defibrillation threshold testing at the time of implantable cardioverter-defibrillator implantation versus no defibrillation threshold testing

Background: Inability to perform defibrillation threshold (DFT) testing during implantable cardioverter defibrillator (ICD) implantation due to co-morbidities may influence long-term survival. Methods: Retrospective review at The University of Michigan (1999-2004) identified 55 patients undergoing ICD implantation without DFT testing (“No-DFT group”). A randomly selected sample of patients (n = 57) undergoing standard DFT testing (“DFT group”) was compared in terms of appropriate shocks, clinical shock efficacy and all-cause mortality. Results: DFT testing was withheld due to hypotension, atrial fibrillation with inability to exclude left atrial thrombus, left ventricular thrombus, CHF and/or ischemia. The No-DFT group had a similar appropriate shock rate, but lower total survival (69.1% vs. 91.2%, p = 0.004) than the DFT group. The No-DFT group had a higher incidence of ventricular fibrillation (VF) episodes (9.1% vs. 3.1%, p = 0.037), and deaths attributable to VF (3 of 17 deaths vs. 0 of 5 deaths) compared to the DFT group. Multivariate analysis found a trend toward increased risk of death in the No-DFT group (HR 3.18, 95% CI 0.82-12.41, p = 0.095) after adjusting for baseline differences in gender distribution, NYHA class and prior CABG. Conclusions: In summary, overall mortality was higher in the No-DFT group. More deaths attributable to VF occurred in the No-DFT group. Thus, DFT testing should therefore remain the standard of care. Nevertheless, ICD therapy should not be withheld in patients who meet appropriate implant criteria simply on the basis of clinical scenarios that preclude routine DFT testing. (Cardiol J 2007; 14: 463-469

Effect of Catheter Ablation on Progression of Paroxysmal Atrial Fibrillation

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90181/1/j.1540-8167.2011.02137.x.pd

Utility of Atrial and Ventricular Cycle Length Variability in Determining the Mechanism of Paroxysmal Supraventricular Tachycardia

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/72411/1/j.1540-8167.2007.00860.x.pd

Effects of Simultaneous Atrioventricular Pacing on Atrial Refractoriness and Atrial Fibrillation Inducibility: Role of Atrial Mechanoelectrical Feedback

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/74794/1/j.1540-8167.2001.00043.x.pd

Effect of Gender on Atrial Electrophysiologic Changes Induced by Rapid Atrial Pacing and Elevation of Atrial Pressure

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/74798/1/j.1540-8167.2001.00986.x.pd